MedPage Today (12/4, Hlavinka) reports, “Patients with chronic or recurrent major depressive disorder [MDD] who achieved recovery had a higher chance of sustaining recovery when they stayed on maintenance antidepressant medication,” researchers concluded in “randomized phase II trial.” The study revealed that “among 292 adults who had achieved recovery with either medication treatment alone or combined with cognitive behavioral therapy…recurrence was significantly less likely among patients who stayed on maintenance therapy compared with those who were withdrawn from medication treatment, regardless of whether they achieved remission through medication alone” or “with combined treatment.”
Psychiatric News (12/4) reports, “Maintenance of antidepressant medication treatment was associated with a reduced risk of depressive recurrence, but previous treatment with cognitive-behavioral therapy was not,” the study revealed. The findings were published online Dec. 4 in JAMA Psychiatry.
Related Links:
— “Study Raises New Questions About How Best to Reduce Risk of Depression Recurrence, Psychiatric News, December 4, 2019